BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells
Oncotarget. 2017 May 23;8(21):35019-35032. doi: 10.18632/oncotarget.16558.ABSTRACTDenosumab,…
Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab
Cell Cycle. 2017 Jun 3;16(11):1022-1028. doi: 10.1080/15384101.2017.1310353.…
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nat Genet. 2017 May;49(5):680-691. doi: 10.1038/ng.3826. Epub…
Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2911-E2919. doi:…
Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
Oncogenesis. 2017 Feb 27;6(2):e299. doi: 10.1038/oncsis.2017.4.ABSTRACTFatty…
Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users
Nutrients. 2017 Feb 10;9(2):121. doi: 10.3390/nu9020121.ABSTRACTMetabolic…
AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy
J Invest Dermatol. 2017 Jun;137(6):1297-1310. doi: 10.1016/j.jid.2017.01.021.…
Nuclear reprogramming of cancer stem cells: Corrupting the epigenetic code of cell identity with oncometabolites
Mol Cell Oncol. 2016 Mar 28;3(6):e1160854. doi: 10.1080/23723556.2016.1160854.…
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427.…
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427.…
Adult T-cell leukemia/lymphoma
Rev Assoc Med Bras (1992). 2016 Oct;62(7):691-700. doi: 10.1590/1806-9282.62.07.691.ABSTRACTAdult…
Antiangiogenic resistance via metabolic symbiosis
Mol Cell Oncol. 2016 Jul 14;3(5):e1211979. doi: 10.1080/23723556.2016.1211979.…
